nobiletin has been researched along with Cardiovascular Stroke in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Z; Liang, Z; Liu, Z; Wu, X; Zeng, L; Zheng, D | 1 |
| Liang, Z; Liu, Z; Qin, Y; Wu, X; Zeng, L; Zhang, G; Zheng, D; Zhu, X | 1 |
| Liang, X; Lu, Y; Mao, Q; Wu, Y | 1 |
3 other study(ies) available for nobiletin and Cardiovascular Stroke
| Article | Year |
|---|---|
Nobiletin ameliorates cardiac impairment and alleviates cardiac remodeling after acute myocardial infarction in rats via JNK regulation.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Flavones; Humans; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Myoblasts; Myocardial Infarction; Myocardium; Rats; Ventricular Remodeling | 2021 |
Nobiletin attenuates adverse cardiac remodeling after acute myocardial infarction in rats via restoring autophagy flux.
Topics: Animals; Antioxidants; Autophagy; Cardiotonic Agents; Cell Line; Flavones; Glucose; Heart; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Oxygen; Rats, Sprague-Dawley | 2017 |
Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats.
Topics: Animals; Apoptosis; Cardiotonic Agents; Embolization, Therapeutic; Flavones; Heart; Male; Malondialdehyde; Myocardial Infarction; Myocardium; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; Superoxide Dismutase; Troponin C; Ventricular Function, Left | 2019 |